Dr. Rioux to Highlight Industry-Leading Clinical Programs in MELAS and Leigh Syndrome Spectrum San Diego, California--(Newsfile Corp. - June 20, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ...

CHOP is a recognized leader in the field of pediatric mitochondrial medicine. "The FDA clearance marks a critical milestone for Thiogenesis and underscores the potential of TTI-0102 to address the ...

In the event that the trial yields positive results and receives FDA clearance, Thiogenesis intends to advance TTI-0102 to a pivotal Phase 2b/3 clinical trial in pediatric Leigh syndrome spectrum.

Their method is the first to directly fix flaws in animals’ mitochondrial DNA, which are responsible for severe and deadly conditions.

Indiana mom dons a mitochondria costume to raise awareness for her daughters battling Leigh’s Disease, a rare and often ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ago, experts from both fields will select the most promising drugs for both ...

“So, got that phone call and I said, ‘Where do we go?’ ... and she referred us out,” Ellie’s mom, Krista Price, said. “She ...